Cargando…
In Vivo Multi-Tissue Efficacy of Peroxisome Proliferator-Activated Receptor-γ Therapy on Glucose and Fatty Acid Metabolism in Obese Type 2 Diabetic Rats
OBJECTIVE: To identify the disturbances in glucose and lipid metabolism observed in Type 2 Diabetes Mellitus (T2DM), we examined the interaction and contribution of multiple tissues (liver, heart, muscle, and brown adipose tissue) and monitored the effects of the PPARγ agonist rosiglitazone (RGZ) on...
Autores principales: | Nemanich, Samuel, Rani, Sudheer, Shoghi, Kooresh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3695080/ https://www.ncbi.nlm.nih.gov/pubmed/23512563 http://dx.doi.org/10.1002/oby.20378 |
Ejemplares similares
-
Genomic and Metabolic Disposition of Non-Obese Type 2 Diabetic Rats to Increased Myocardial Fatty Acid Metabolism
por: Devanathan, Sriram, et al.
Publicado: (2013) -
Sexual dimorphism in myocardial acylcarnitine and triglyceride metabolism
por: Devanathan, Sriram, et al.
Publicado: (2016) -
Targeting the Peroxisome Proliferator-Activated Receptor-γ to Counter the Inflammatory Milieu in Obesity
por: Corzo, Cesar, et al.
Publicado: (2013) -
Effects of Sulfonylureas on Peroxisome Proliferator-Activated Receptor γ Activity and on Glucose Uptake by Thiazolidinediones
por: Lee, Kyeong Won, et al.
Publicado: (2011) -
A role of peroxisome proliferator‐activated receptor γ in non‐alcoholic fatty liver disease
por: Skat‐Rørdam, Josephine, et al.
Publicado: (2019)